AU1212501A - Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment - Google Patents

Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment

Info

Publication number
AU1212501A
AU1212501A AU12125/01A AU1212501A AU1212501A AU 1212501 A AU1212501 A AU 1212501A AU 12125/01 A AU12125/01 A AU 12125/01A AU 1212501 A AU1212501 A AU 1212501A AU 1212501 A AU1212501 A AU 1212501A
Authority
AU
Australia
Prior art keywords
compounds
gram
treatment
methods
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU12125/01A
Inventor
Amjad Ali
Donald W. Graham
Gayle E. Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU1212501A publication Critical patent/AU1212501A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU12125/01A 1999-10-21 2000-10-18 Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment Withdrawn AU1212501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16081399P 1999-10-21 1999-10-21
US60160813 1999-10-21
PCT/US2000/028786 WO2001028561A1 (en) 1999-10-21 2000-10-18 Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment

Publications (1)

Publication Number Publication Date
AU1212501A true AU1212501A (en) 2001-04-30

Family

ID=22578562

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12125/01A Withdrawn AU1212501A (en) 1999-10-21 2000-10-18 Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment

Country Status (2)

Country Link
AU (1) AU1212501A (en)
WO (1) WO2001028561A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139435A1 (en) 2001-06-26 2003-07-24 Gulzar Ahmed N-heterocyclic inhibitors of TNF-alpha expression
EP1465900B1 (en) 2002-01-10 2008-05-14 Bayer HealthCare AG Rho-kinase inhibitors
US6943172B2 (en) 2002-01-23 2005-09-13 Bayer Pharmaceuticals Corporation Rho-kinase inhibitors
JP4469179B2 (en) 2002-01-23 2010-05-26 バイエル ファーマセチカル コーポレーション Pyrimidine derivatives as Rho kinase inhibitors
CA2473724A1 (en) 2002-02-08 2003-08-14 Glsynthesis Inc. Purine and isosteric antibacterial compounds
DE10226943A1 (en) * 2002-06-17 2004-01-08 Bayer Ag Phenylaminopyrimidines and their use
US20050014753A1 (en) * 2003-04-04 2005-01-20 Irm Llc Novel compounds and compositions as protein kinase inhibitors
DE102004020570A1 (en) 2004-04-27 2005-11-24 Bayer Healthcare Ag Substituted phenylaminopyrimidines
TW201016676A (en) * 2008-10-03 2010-05-01 Astrazeneca Ab Heterocyclic derivatives and methods of use thereof
CA2772907C (en) 2009-09-11 2018-01-09 Glsynthesis Inc. Selective antibacterials for clostridium difficile infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3152112A (en) * 1964-10-06 Phenylazo- and phenylhydrazo-
DE3717480A1 (en) * 1987-05-23 1988-12-01 Shell Agrar Gmbh & Co Kg Novel herbicidal and microbicidal 2,6-diaminopyrimidines

Also Published As

Publication number Publication date
WO2001028561A1 (en) 2001-04-26

Similar Documents

Publication Publication Date Title
MXPA03003168A (en) Topical antibiotic composition for treatment of eye infection.
ZA973487B (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment.
HK1150756A1 (en) Antibiotic compositions for treatment of the ear
AU4772699A (en) Antimicrobial hair treatment composition
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
AU6157700A (en) Malodour treatment compositions
AU2247701A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
AU5029700A (en) Glycopeptide antibacterial compounds, compositions containing same and methods of using same
AU1702301A (en) Hair treatment composition
AU1212501A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
HUP9901778A3 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU1212201A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
AU1646701A (en) Composition for treating respiratory tract infections
AU1261601A (en) Treatment of C. difficile toxin B associated conditions
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
ZA991410B (en) Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
EP1084105A4 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
EP1021445A4 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
EP1027352A4 (en) Carbapenem antibacterial compounds, compositions and methods of treatment
EP1032384A4 (en) Carbapenem antibacterial compounds, compositions and methods of treatment
EP1089729A4 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
EP1089730A4 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
EP0977567A4 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
EP1027353A4 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU4706799A (en) Treatment of (staphylococcus) infections

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant